age limits on pneumo vaccinations
Routine Recommendations. for Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23) Risk Group. Administer PCV13 series to all children beginning. at age 2 months, followed by doses at 4 months, 6 months, and 12â15 months (booster dose). Administer 1-time dose to PCV13-naÃ¯ve adults. at age 65 years, followed by a dose of PPSV23.